





























	 Condensation	 of	 1H‐1,2,4‐triazol‐5‐amine	 with	 the	 appropriate	 sodium	 (E)‐(2‐oxocycloalkylidene)methanolate	 gave	 7,8‐dihydro‐6H‐cyclopenta[e][1,2,4]triazolo	 [1,5‐
a]pyrimidine,	 6,7,8,9‐tetrahydro‐[1,2,4]triazolo[1,5‐a]quinazoline,	 7,8,9,10‐tetra	 hydro‐
6H‐cyclohepta[e][1,2,4]triazolo[1,5‐a]pyrimidine	and	6,7,8,9,10,11‐hexahydro	cycloocta













Triazolopyrimidines	 represent	 a	 pharmaceutically	
important	class	of	compounds	because	of	their	diverse	range	of	
biological	 activities,	 such	 as	 antitumor	 [1],	 cytotoxicity	 [2],	
therapeutic	 potentiality	 [3],	 potent	 and	 selective	 ATP	 site	
directed	inhibition	of	the	EGF‐receptor	protein	tyrosine	kinase	
[4]	and	cardiovascular	[5]	activities.	In	addition,	they	have	been	
found	 in	 DNA‐interactive	 drugs	 [6]	 and	 as	 useful	 building	
blocks	 in	 the	 synthesis	 of	 herbicidal	 drugs,	 e.g.	 Metosulam,	
Flumetsulam,	 Azafenidin,	Diclosulam,	 Penoxsulam,	 Floransulan,	
Cloransulam	etc.	Also,	various	derivatives	of	1,2,4‐triazolo[4,3‐
a]pyrimidine	 were	 reported	 to	 be	 useful	 as	 calcium‐channel‐
blocking	 vasodilators,	 some	 have	 antihypertensive	 [7],	
cardiovascular	[8,9]	and	anxiolytic	[10]	activities.	
In	view	of	these	reports	and	in	continuation	of	our	interest	
in	 the	 synthesis	 of	 a	 variety	 of	 heterocyclic	 systems	 for	
biological	 evaluation	 [11‐17],	 we	 describe	 herein	 a	 facile	
synthesis	 of	 some	 new	 1,2,4‐triazolo[5,1‐a]pyrimidine	 deriva‐
tives	 and	 study	 the	 anti‐carcinogenic	 effects	 of	 two	 newly	
synthesized	 derivatives,	 7,8‐dihydro‐6H‐cyclopenta[e][1,2,4]	
triazolo[1,5‐a]pyrimidine	 and	 6,7,8,9,10,11‐hexahydrocyclo	






All	melting	 points	were	 determined	 on	 an	 Electrothermal	
apparatus	and	are	uncorrected.	IR	spectra	were	recorded	(KBr	
discs)	 on	 a	 Shimadzu	 FT‐IR	 8201	 PC	 spectrophotometer.	 1H	
NMR	and	13C	NMR	spectra	were	recorded	in	CDCl3	on	a	Varian	
mercury	 VXR‐300	 (300	 MHz	 for	 1H	 and	 75	 MHz	 for	 13C).	
Chemical	shifts	are	expressed	 in		ppm	units	using	TMS	as	an	








0.01	 mol),	 and	 diethyl	 ether	 (20	 mL),	 the	 appropriate	
cyclopentanone,	 cyclohexanone,	 cycloheptanone	 or	 cyclo‐
octanone	 (0.01)	mol	with	 ethyl	 formate	 (7.5	 g,	 0.01	mol)	was	
poured	over	it	through	separating	funnel	with	efficient	stirring.	













acid	was	 thoroughly	 ground	with	pestle	 in	 an	open	mortar	 at	
room	temperature	 for	3‐5	min	until	 the	mixture	 turned	 into	a	
melt.	Grinding	of	 the	 initial	 syrupy	 continued	 for	5‐7	min	and	
the	 progress	 of	 the	 reaction	 was	 monitored	 by	 TLC.	 The	
remaining	 solid	 was	 filtered,	 washed	 with	 water	 and	
recrystallized	 from	 chloroform	 gave	 the	 corresponding	 fused	
pyrimidines	6a‐d,	respectively.	
Method	B:	A	solution	of	the	appropriate	of	compound	2a‐d	
(5	 mmol),	 1H‐1,2,4‐triazol‐5‐amine	 5	 (0.42	 g,	 5	 mmol))	 and	
piperidinium	acetate	(1	mL)	in	H2O	(3	mL)	was	refluxed	for	15	
min.	Acetic	acid	(1	mL)	was	added	to	the	hot	solution.	The	solid	







1H,	 triazole	 H‐3).	 13C	 NMR	 (75	 MHz,	 CDCl3,	 δ,	 ppm):	 21.55,	





Color:	 Pale	 yellow	 crystals.	 Yield:	 94%.	 M.p.:	 189‐190	 °C.	 1H	
NMR	(300	MHz,	CDCl3,	δ,	ppm):	1.85‐2.22	(m,	4H,	2CH2),	2.85‐
2.95	 (m,	 2H,	 CH2),	 3.15‐3.24	 (m,	 2H,	 CH2),	 8.21	 (s,	 1H,	
pyrimidine	H‐4),	 8.48	 (s,	 1H,	 triazole	H‐3).	 13C	NMR	 (75	MHz,	





pyrimidine	 (6c):	 Color:	 Yellow	 crystals.	 Yield:	 95%.	M.p.:	 199‐
200	 °C.	 1H	NMR	 (300	MHz,	 CDCl3,	 δ,	 ppm):	 1.60‐1.90	 (m,	 4H,	
CH2),	2.70‐2.80	(d,	1H,	J	=	6	Hz,	CH2),	2.85	(t,	2H,	J	=	6	Hz,	CH2),	
3.15	(d,	1H,	CH),	3.5	(t,	2H,	J	=	6	Hz,	CH2),	8.30	(d,	1H,	J	=	6Hz,	
pyrimidine	H‐4),	 8.50	 (d,	1H,	 J	 =	 6	Hz,	 triazole	H‐3).	 13C	NMR	
(75	 MHz,	 CDCl3,	 δ,	 ppm):	 22.96,	 26.52,	 26.99,	 28.52,	 28.58,	
115.16,	 148.34,	 154.18,	 156.05,	 162.08.	 FT‐IR	 (KBr,	 ν,	 cm‐1):	





220	 °C.	 1H	 NMR	 (300	MHz,	 CDCl3,	 δ,	 ppm):	 1.35‐150	 (m,	 4H,	
2CH2),	1.80‐1.90	(m,	4H,	2CH2),	2.92	(t,	2H,	J	=	6	Hz,	CH2),	3.45	
(t,	2H,	J	=	6	Hz,	CH2),	8.50	(s,	1H,	pyrimidine	H‐4),	8.70	(s,	1H,	
triazole	H‐3).	 13C	NMR	 (75	MHz,	 CDCl3,	 δ,	 ppm):	 23.59,	 26.49,	
27.27,	 27.59,	 29.12,	 30.33,	 115.87,	 148.34,	 154.15,	 156.76,	
162.08.	 FT‐IR	 (KBr,	 ν,	 cm‐1):	 3312,	 2976,	 1620.	 MS	 (m/z,	
(%)):203	 (M+1,	 12),	 202	 (M+,	 100),	 187	 (35),	 174	 (45),	 189	









Human	 hepatocarcinoma	 cell	 lines	 (HepG2)	 and	 breast	
carcinoma	 cell	 lines	 (MCF7)	used	 in	 this	 study	were	obtained	
from	 the	 American	 Type	 Culture	 Collection	 (ATCC,	 Minisota,	





The	 two	 derivatives,	 7,8‐dihydro‐6H‐cyclopenta[e][1,2,4]	
triazolo[1,5‐a]pyrimidine	 and	 6,7,8,9,10,11‐hexahydrocyclo‐
octa[e][1,2,4]triazolo[1,5‐a]pyrimidine	 were	 prepared	 by	
dissolving	1:1	 stock	 solution	 and	 stored	 at	 ‐20	 °C	 in	dimethyl	







Dimethylsulphoxide	 (DMSO),	 RPMI‐1640	 medium,	 trypan	
blue,	 Fetal	 Bovine	 Serum,	 Penicillin/	 Streptomycin	 antibiotic	
and	Trypsin‐EDTA	were	obtained	from	Sigma	Aldrich	Chemical	
Co.,	 St.	 Louis,	 Mo,	 U.S.A..	Tris‐buffer	was	 obtained	 Applichem,	







2. Fetal	 Bovine	 Serum	 (FBS):	 10	 %	 concentration	 was	
prepared	 and	 used	 for	 supplementation	 of	 RPMI1640	
medium	prior	to	use.	
3. Penicillin/Streptomycin:	 100	 units/mL	 penicillin/2	
mg/mL	 streptomycin	 were	 used	 for	 the	 supplemen‐
tation	of	RPMI‐1640	medium	prior	to	use.	
4. Trypsin‐EDTA:	 0.25	 %	 solution	 containing	 2.5	 g/L	
Porcine	trypsin	and	0.38	g/L	EDTA.4H2O	was	used	 for	
the	harvesting	of	cells.	
5. Glacial	 acetic	 acid:	 1	 %	 was	 used	 for	 dissolving	 the	
unbound	SRB	dye.	
6. Sulphorhodamine‐B	 (SRB):	 0.4	 %	 concentration	 was	
dissolved	in	1	%	acetic	acid	was	used	as	a	protein	dye.	
7. Trichloroacetic	 acid	 (TCA):	 50	 %	 stock	 solution	 was	
prepared,	 10	 %	 solution	 was	 used	 for	 protein	
precipitation.	
8. Tris	 base,	 10	mM,	 (pH	 =	 10.5)	 was	 used	 for	 SRB	 dye	
solubilization.	It	was	prepared	by	dissolving	121.1	g	of	





RPMI‐1640	 medium	 was	 used	 for	 culturing	 and	
maintenance	 of	 the	human	 tumor	 cell	 lines.	 The	medium	was	
supplied	in	a	powder	form.	The	working	solution	was	prepared	
by	 dissolving	 10.4	 g	 powder	 and	 2	 g	 sodium	 bicarbonate	
dissolved	in	1	L	distilled	water.	The	medium	was	then	sterilized	
by	 filtration	 in	 a	 Millipore	 bacterial	 filter	 (0.22	 μm).	 The	
prepared	medium	was	kept	in	a	refrigerator	(4	°C).	Before	use,	









A	 cryotube	 containing	 frozen	 cells	 was	 taken	 out	 of	 the	
liquid	nitrogen	container	and	then	thawed	in	a	water	bath	at	37	
°C.	 The	 cryotube	 was	 opened	 under	 strict	 aseptic	 conditions	
and	its	contents	were	supplied	by	5	mL	supplemented	medium	
drop	 by	 drop	 in	 a	 50	 mL	 sterile	 falcon	 tubes.	 The	 tube	 was	
incubated	for	2	hours	then	centrifuged	at	1200	rpm	for	10	min	
and	 the	 supernatant	 was	 discarded.	 The	 supernatant	 was	
discarded	and	the	cell	pellet	was	suspended	and	seeded	in	5	mL	
supplemented	 medium	 in	 T25	 Nunclon	 sterile	 tissue	 culture	
flasks.	The	cell	suspension	was	incubated	and	followed	up	daily	
the	 supplemented	 medium	 was	 replaced	 every	 2‐3	 days.	
Incubation	 was	 continued	 until	 a	 confluent	 growth	 was	





The	 medium	 was	 discarded.	 The	 monolayer	 cell	 was	
washed	 twice	 with	 5	 ml	 phosphate	 buffered	 saline.	 All	 the	
adherent	 cells	 were	 dispersed	 from	 their	 monolayer	 by	 the	







inverted	 microscope	 using	 the	 haemocytometer.	 Non	 stained	











To	 avoid	 the	 loss	 of	 the	 cell	 line,	 excess	 cells	 were	
preserved	in	liquid	nitrogen.	Equal	parts	of	the	cell	suspension	
and	 freezing	medium	(10	%	DMSO	 in	supplemented	medium)	
were	 dispersed	 to	 cryotubes.	 The	 cryotubes	 were	 racked	 in	
appropriately	 labeled	 polystyrene	 boxes,	 gradually	 cooled	 till	







(SRB)	 assay	 following	 the	 method	 reported	 by	 Vichai	 and	
Kirtikara	[13]	and	Hussein	and	Ahmed	[14,15].	SRB	is	a	bright	
pink	 aminoxanthrene	 dye	 with	 two	 sulphonic	 groups.	 It	 is	 a	
protein	 stain	 that	 binds	 to	 the	 amino	 groups	 of	 intracellular	
proteins	 under	mildly	 acidic	 conditions	 to	provide	 a	 sensitive	
index	of	cellular	protein	content.	
Cells	 were	 maintained	 in	 RPMI‐1640	 medium	 with	 10%	
foetal	calf	serum,	sodium	pyruvate,	100	U/mL	penicillin	and	2	
mg/mL	streptomycin	at	37	°C	and	5%	CO2.	Cells	were	seeded	in	
96‐well	 micro	 titer	 plates	 at	 initial	 concentration	 of	 3×103	
cell/well	 in	 a	 150	 µL	 fresh	 medium	 and	 left	 for	 24	 hours	 to	
attach	to	the	plates.	Different	concentrations	0,	5,	12.5,	25,	and	
50	 µg/mL	 of	 the	 tested	 compounds	 were	 added.	 For	 each	
concentration,	 3	 wells	 were	 used.	 The	 plates	 were	 incubated	
for	 48	 hours.	 The	 cells	 were	 fixed	 with	 50	 μL	 cold	
trichloroacetic	acid	10%	final	concentration	for	1	hour	at	4	°C.	
The	plates	were	washed	with	distilled	water	using	(automatic	
washer	 Tecan,	 Germany)	 and	 stained	 with	 50	 μL	 0.4	 %	 SRB	
dissolved	 in	 1	 %	 acetic	 acid	 for	 30	 minutes	 at	 room	
temperature.	The	plates	were	washed	with	1	%	acetic	acid	and	
air‐dried.	The	dye	was	solubilized	with	100	μL/well	of	10	M	tris	
base	 (pH	 =	 10.5)	 and	 optical	 density	 (O.D.)	 of	 each	well	 was	
measured	 spectrophotometrically	 at	 570	 nm	 with	 an	 ELISA	
micro	plate	reader	(Sunrise	Tecan	reader,	Germany).	The	mean	
background	 absorbencies	 were	 automatically	 subtracted	 and	
mean	 values	 of	 each	 drug	 concentration	 was	 calculated.	 The	
experiment	 was	 repeated	 3	 times.	 The	 percentage	 of	 cell	
survival	was	calculated	using	the	formula,	surviving	fraction	=	
O.D.	 (treated	 cells)/O.D.	 (control	 cells).	 The	 IC50	 values	 (the	








(2‐oxocyclooctylidene)methanolate	 (2d)	 in	 acetic	 acid	




midine	 (9d)	 (Scheme	 1).	 The	 structure	 was	 confirmed	 by	
elemental	 analysis,	 spectral	 data	 and	 X‐ray	 single	 crystal	
diffraction	data	(Figure	1)	(Table	1	and	2).	The	reaction	seemed	
to	be	via	 the	 initial	nucleophilic	attack	by	 the	exocyclic	amino	
group	 at	 the	 formyl	 group	 4,	 which	 formed	 in	 situ	 from	
compound	 2d	 with	 water,	 followed	 by	 cyclization	 and	



















































Many	 triazolopyrimidine	 derivatives	 were	 previously	




























































the	 dose	 was	 increased	 from	 5	 to	 50	 µg/mL.	 The	 IC50	 of	
6,7,8,9,10,11‐hexahydrocycloocta[e][1,2,4]triazolo[1,5‐a]	 pyri‐
midine	 and	 7,8‐dihydro‐6H‐cyclopenta[e][1,2,4]triazolo[1,5‐
a]pyrimidine	 against	 HepG2	 was	 12.13	 µg/mL	 and	 14.75	
µg/mL,	respectively	(Figure	2	and	3).	
Similar	 to	 the	 effect	 on	 HepG2,	 the	 two	 tested	
triazolopyrimidine	 derivatives	 had	 potential	 cytotoxic	 effects	
on	 breast	 carcinoma	 cell	 lines	 (MCF7).	 The	 survival	 fraction	

































Synthesis	 of	 new	 [1,2,4]triazolo[1,5‐a]pyrimidine	 deriva‐
tives	 was	 accomplished	 and	 structures	 were	 elucidated	 by	
means	of	various	characterization	techniques	such	as	elemental	
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